Syncytial virus pneumonia is generally referred to as pneumonia caused by respiratory syncytial virus infection, which is potentially curable but can be life-threatening in people with poor immunity. Pneumonia caused by respiratory syncytial virus infection is relatively common in infants and young children. Currently, there is no specific drug, and active symptomatic treatment is the mainstay of treatment, with antiviral drugs such as ribavirin used to treat severe cases or those with high-risk factors, and antibiotics such as ceftriaxone sodium and amoxicillin may be needed to control the disease in the case of bacterial infections, which may lead to a complete cure. However, infants under 6 months of age, the elderly, people with basic cardiopulmonary diseases and immunocompromised people may develop serious clinical manifestations and complications, even life-threatening. Therefore, respiratory syncytial virus pneumonia requires prompt medical attention, active antiviral treatment and close monitoring of the disease. The above medications should be used in a standardized and rational manner under the guidance of professional physicians and pharmacists. If the symptoms fail to improve or even worsen gradually, you should consult a regular hospital and cooperate with the doctor to improve the examination and standardize the treatment.